Mordovia State University
Saransk, Russian Federation
University in Saransk
Bol'shevistskaya Ulitsa, 68, Saransk, Mordovia Republic, 430005
About Mordovia State University
N. P. Ogarev's Mordovia State University is located in the city of Saransk in the Republic of Mordovia, Russia. The university offers bachelor's and master's degrees in various academic fields.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
5
Promomed, LLC
2
Apollomics Inc.
1
Celgene
1
Elevar Therapeutics
1
Gliknik Inc.
1
Jounce Therapeutics, Inc.
1
Mylan Pharmaceuticals Inc
1
Polyphor Ltd.
1
Valenta Pharm JSC
1
Clinical Trials at Mordovia State University
During the past decade, Mordovia State University conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 6 clinical trials were completed, i.e. on
average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110]
2015-07-20
2022-03-08
Completed
572
A Study of Atezolizumab Compared With Gemcitabine Plus (+) Cisplatin or Carboplatin for PD-L1-Selected Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower111)
2015-05-07
2017-12-07
Terminated
8
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]
2015-10-31
2027-12-17
Active, not recruiting
1,280
Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral Cavity
2017-03-30
2021-05-25
Completed
80
A Study to Evaluate Rivoceranib Plus Best Supportive Care Compared to Placebo Plus Best Supportive Care in Participants With Gastric Cancer
2017-03-14
2020-09-23
Completed
460
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
2017-09-27
2026-11-30
Recruiting
344
Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Children 7-12 y.o.
2014-08-01
2015-03-01
Completed
310
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
2018-08-02
2025-08-24
Active, not recruiting
2,300
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Mordovia State University" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Promomed, LLC" with 2 trials
sponsored, "Apollomics Inc." with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Elevar Therapeutics"
with 1 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Mordovia State University"
#1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Atlant Clinical Ltd." with 1 trials as a collaborator, "BeiGene" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at Mordovia State University
According to Clinical.Site data, the most researched conditions in "Mordovia State University" are
"Non-Small Cell Lung Cancer" (3 trials), "COVID-19" (2 trials), "Gastric Cancer" (2 trials), "NSCLC" (2 trials) and "Acute Respiratory Infection" (1 trials). Many other conditions were trialed in "Mordovia State University" in a lesser frequency.
Clinical Trials Intervention Types at Mordovia State University
Most popular intervention types in "Mordovia State University" are "Drug" (14 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (4 trials), "Cisplatin" (3 trials), "Gemcitabine" (3 trials), "Placebo" (3 trials) and "Carboplatin" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Mordovia State University
The vast majority of trials in "Mordovia State University" are
15 trials for "All" genders.
Clinical Trials Status at Mordovia State University
Currently, there are NaN active trials in "Mordovia State University".
undefined are not yet recruiting,
1 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Mordovia State University,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Mordovia State University, 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".